5 completed, 1 no longer available, 1 terminated, 1 withdrawn. 5 Phase 1, 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Terminated 1, Withdrawn 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Blaze Bioscience Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery Near Infrared Imaging, Therapeutic Conventional Surgery, Tozuleristide - Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8 | Phase 1 / Phase 2 | Terminated | University of Washington | 8 | 2024-04-17 | 2026-09-16 |
| Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System tozuleristide, Canvas imaging system, Surgical resection of tumor - Central Nervous System Tumor | Phase 2 | Completed | John Yu | 50 | 2021-09-30 | 2026-07-10 |
| Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery tozuleristide, Canvas System - Pediatric Central Nervous System Tumor | Phase 2 / Phase 3 | Completed | Blaze Bioscience Inc. | 118 | 2018-11-26 | 2024-06-27 |
| Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery BLZ-100 - Sarcoma, Soft Tissue | Phase 1 | Withdrawn | Blaze Bioscience Inc. | 2015-09-01 | 2016-05-26 | |
| Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery BLZ-100 - Tumors, Breast | Phase 1 | Completed | Blaze Bioscience Inc. | 30 | 2015-07-01 | 2017-07-13 |
| Study of BLZ-100 in Pediatric Subjects With CNS Tumors BLZ-100 - Central Nervous System Tumors | Phase 1 | Completed | Blaze Bioscience Inc. | 29 | 2015-06-01 | 2023-02-21 |
| Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery BLZ-100 - Glioma | Phase 1 | Completed | Blaze Bioscience Inc. | 17 | 2014-10-01 | 2016-04-06 |
| Expanded Access for BLZ-100 (Tozuleristide) Tozuleristide | No longer available | Blaze Bioscience Inc. | 2025-04-04 |
Brain Neoplasms (3) · Central Nervous System Neoplasms (3) · Glioma (2) · Astrocytoma (1) · Breast Neoplasms (1) · Craniopharyngioma (1) · Ependymoma (1) · Glioblastoma (1) · Medulloblastoma (1) · Meningioma (1) · Mouth Neoplasms (1) · Neoplasms, Germ Cell and Embryonal (1) · Neuroma, Acoustic (1) · Pinealoma (1) · Sarcoma (1)
tozuleristide (8)
United States (7) · Australia (1)
Charles Forscher, MD (1) · Chirag Patil (1) · Emily Marchiano (1) · John Yu, MD (1) · Kristi M Harrington, MD (1) · Sarah Leary, MD (1) · Sarah Leary, MD, MS (1)
261201400046C-0-0-1 (1)